Colloidal formulation of mistletoe extracts in a pharmaceutical flow process for targeted cancer therapy

Publication date

2019

Authors

Leneweit, Gero
Miranda, Bárbara S.
de Matos, Maria B CISNI 0000000506344880
Beztsinna, NataliiaISNI 0000000505885108
Heyder, ChristophISNI 0000000138837939
Dührkop, Claudia
Nirschl, Hermann
Ekdahl, Kristina Nilsson
Nilsson, Bo
Mastrobattista, EnricoORCID 0000-0002-6745-2015ISNI 000000035187179X

Editors

Advisors

Supervisors

Document Type

Article
Open Access logo

License

taverne

Abstract

Keywords

Liposomes, mistletoe, encapsulation of biopharmaceuticals, tumour targeting, triggered release, inhibition of complement activation, Taverne, SDG 3 - Good Health and Well-being

Citation

Leneweit, G, Miranda, B S, de Matos, M B C, Beztsinna, N, Heyder, C, Dührkop, C, Nirschl, H, Ekdahl, K N, Nilsson, B, Mastrobattista, E & Kok, R J 2019, 'Colloidal formulation of mistletoe extracts in a pharmaceutical flow process for targeted cancer therapy', Phytomedicine, vol. 61, no. Supplement 1. https://doi.org/10.1016/j.phymed.2019.09.118